GLP-1 Drugs Like Ozempic Might Cut Cancer Risk Too, Study FindsObesity treatment drugs show potential anticancer effects, proving 41% more effective than surgery in preventing obesity-related cancers.
Wegovy or Wait? New Pills Could Reshape the Weight Loss Treatment LandscapeThe obesity treatment market is shifting with new oral medications emerging, offering alternatives to injectable options.
Eli Lilly Moves First in India, Beats Novo in Obesity Drug ShowdownEli Lilly launches Mounjaro in India, targeting a large market and competing with Novo Nordisk's Wegovy for obesity treatment.
Must-Reads
1
Arrest warrants issued for 48 suspects brought from Cambodia
LATEST
2
S. Korea's exports down 7.8% in first 20 days of Oct.
LATEST
3
S. Korean man found dead in Cambodia: foreign ministry
LATEST
4
Remains of late S. Korean student tortured to death in Cambodia arrive home
LATEST
5
Trump expects 'fantastic' trade deal with China, notes 'fair' deals with S. Korea, Japan, EU
GLP-1 Drugs Like Ozempic Might Cut Cancer Risk Too, Study Finds Obesity treatment drugs show potential anticancer effects, proving 41% more effective than surgery in preventing obesity-related cancers.
Wegovy or Wait? New Pills Could Reshape the Weight Loss Treatment Landscape The obesity treatment market is shifting with new oral medications emerging, offering alternatives to injectable options.
Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown Eli Lilly launches Mounjaro in India, targeting a large market and competing with Novo Nordisk's Wegovy for obesity treatment.
Hot Topics